Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HQL
HOLDREMOVEAbrdn Life Sciences Investors · Financial Services · United States · $537M · Avg Vol: $2M/d
Abrdn Life Sciences Investors is a closed-end fund with very low quality metrics, and we prefer owning concentrated, direct equity stakes rather than paying layered fees for a diversified fund.
COMPANY DESCRIPTION
abrdn Life Sciences Investors is a closed-end fund that invests in public and private companies within the life sciences industry, including biotechnology, pharmaceuticals, and medical devices. The fund's competitive advantage lies in its ability to invest a portion of its assets in venture-stage, privately held companies, offering retail investors rare access to early-stage healthcare innovations. It is managed by abrdn's specialized healthcare team, targeting long-term capital appreciation through a diversified portfolio of cutting-edge science companies.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | -103M | 24M | 87M | 86M | 91.6% |
| EPS | 2.66 | -4.26 | 0.79 | 3.04 | — | 4.6% |
| Shares | — | 26M | 27M | 28M | 30M | +15.3% |
| Debt | — | 17M | 666,959 | 888,610 | 2M | -53.2% |
| Equity | — | 398M | 402M | 460M | 514M | 8.9% |
| Op CF | — | — | — | — | 32M | — |
| Inv CF | — | — | — | — | — | — |
| Fin CF | — | — | — | — | -32M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of HQL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HQL | Abrdn Life Sciences Investors(you) | $537M | 60 | HOLD |
| NMCO | Nuveen Municipal Credit Opportunities Fund | $598M | 58 | HOLD |
| GUT | The Gabelli Utility Trust | $558M | 63 | HOLD |
| BGY | BlackRock Enhanced International Dividend Trust | $522M | 55 | HOLD |
| FFA | First Trust Enhanced Equity Income Fund | $460M | 62 | HOLD |
| DSU | BlackRock Debt Strategies Fund, Inc. | $619M | 56 | HOLD |
| ECC | Eagle Point Credit Company | $554M | 52 | HOLD |
| GAIN | Gladstone Investment Corporation | $587M | 67 | BUY |
| GLAD | Gladstone Capital Corporation | $437M | 54 | HOLD |
| FFC | Flaherty & Crumrine Preferred Securities Income Fund Inc. | $774M | 62 | HOLD |
Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%